Key facts
- Apratima Biosolutions’s last known valuation is $960K (Jun 2025).
- It has raised $90K; the latest was Early Stage VC ($90K) in Jun 2025.
- Notable investors include Rainmatter Capital, Centre for Cellular And Molecular Platforms, Foundation for Science Innovation and Development, NSRCEL-IIMB.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Apratima Biosolutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Apratima Biosolutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Apratima Biosolutions
Developer of low-carbon footprint technology intended to degrade plastic waste. The company specializes in utilizing natural molecular tools and artificial intelligence to engineer proteins capable of breaking down plastic waste into its building blocks, which can then be reused to create virgin-quality polymers, enabling clients to have a sustainable, eco-friendly method and high-quality recycled products.
- Sector
- Business Products and Services (B2B)
- HQ
- Bangalore, India
- Founded
- 2022
- Employees
- 6
- Website
- apratima.com/
- Ownership
- Privately Held (backing)
Apratima Biosolutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Apratima Biosolutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Apratima Biosolutions in its N-PORT filings yet. We sweep new filings monthly.